> top > docs > PMC:7228307 > spans > 37951-38257 > annotations

PMC:7228307 / 37951-38257 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
640 301-305 Gene denotes FcγR Gene:2213
641 131-135 Gene denotes FcγR Gene:2213

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T341 123-126 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T342 179-184 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T21 179-184 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T692 131-133 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T693 173-174 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T694 179-184 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T695 301-303 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
641 131-135 Gene denotes FcγR Gene:2213

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T216 0-306 Sentence denotes The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR.

LitCovid-sample-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T21 179-184 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T340 123-126 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T341 179-184 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T216 0-306 Sentence denotes The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR.